PubMed:25975632 9 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 24-35 | CI | denotes | bevacizumab |
| T31 | 45-54 | CI | denotes | docetaxel |
| T7 | 67-79 | CI | denotes | fluorouracil |
| T9 | 81-91 | CI | denotes | epirubicin |
| T10 | 97-113 | CI | denotes | cyclophosphamide |
| T35 | 150-163 | DP | denotes | breast cancer |
| T14 | 305-316 | CI | denotes | bevacizumab |
| T36 | 377-390 | DP | denotes | breast cancer |
| T37 | 528-541 | DP | denotes | breast cancer |
| T32 | 741-750 | CI | denotes | docetaxel |
| T6 | 812-824 | CI | denotes | fluorouracil |
| T8 | 840-850 | CI | denotes | epirubicin |
| T11 | 870-886 | CI | denotes | cyclophosphamide |
| T22 | 921-926 | CI | denotes | D-FEC |
| T12 | 960-971 | CI | denotes | bevacizumab |
| T19 | 984-987 | CI | denotes | Bev |
| T23 | 988-993 | CI | denotes | D-FEC |
| T24 | 1421-1426 | CI | denotes | D-FEC |
| T20 | 1439-1442 | CI | denotes | Bev |
| T25 | 1443-1448 | CI | denotes | D-FEC |
| T15 | 1556-1567 | CI | denotes | bevacizumab |
| T18 | 1715-1718 | CI | denotes | Bev |
| T26 | 1719-1724 | CI | denotes | D-FEC |
| T27 | 1784-1789 | CI | denotes | D-FEC |
| T21 | 1934-1937 | CI | denotes | Bev |
| T28 | 1938-1943 | CI | denotes | D-FEC |
| T29 | 1962-1967 | CI | denotes | D-FEC |
| T16 | 2041-2052 | CI | denotes | bevacizumab |
| T30 | 2056-2061 | CI | denotes | D-FEC |
| T38 | 2085-2098 | DP | denotes | breast cancer |
| T34 | 2446-2459 | DP | denotes | breast cancer |
| T17 | 2522-2533 | CI | denotes | bevacizumab |